OptiNose
OPTN
OPTN was delisted on the 20th of May, 2025.
77 hedge funds and large institutions have $199M invested in OptiNose in 2019 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 16 reducing their positions, and 9 closing their positions.
81% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 16
44% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 9
5% more funds holding
Funds holding: 73 → 77 (+4)
5% more capital invested
Capital invested by funds: $189M → $199M (+$10.1M)
0.22% more ownership
Funds ownership: 4.35% → 4.57% (+0.22%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TA
Tamarack Advisers
Carlsbad,
California
|
+$4.49M |
| 2 |
WCM
Wildcat Capital Management
New York
|
+$3.45M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.92M |
| 4 |
JP Morgan Chase
New York
|
+$1.22M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$1.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$4.22M |
| 2 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
-$1.89M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.02M |
| 4 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
-$641K |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$326K |
OPTN Hedge Fund Activity: Q3 2019 in Review
77 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in OptiNose (OPTN) for Q3 2019, worth a combined $199M — up 5.3% from $189M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new OPTN positions and 9 closed out — a net gain of 4 holders — while 29 added to existing stakes and 16 trimmed.
The largest buyer was Tamarack Advisers, opening a new position worth an estimated $4.49M. The largest seller was Broadfin Capital, exiting entirely with an estimated $4.22M sold.
- 77 institutional investors held OptiNose (OPTN) as of Q3 2019, up from 73 in Q2 2019.
- Funds reported $199M of OptiNose stock for Q3 2019, up 5.3% quarter-over-quarter.
- 13 funds opened new OptiNose positions in Q3 2019 and 9 closed out, a net change of +4 holders.
- The largest OptiNose buyer in Q3 2019 was Tamarack Advisers, an estimated $4.49M added.
- The largest OptiNose seller in Q3 2019 was Broadfin Capital, an estimated $4.22M sold.
Based on aggregated 13F filings for Q3 2019.